About Us

Zhongke Jianlan is an international platform for medical science translation founded with the support of Chinese Academy of Sciences and Beijing Major Special Projects, focusing on the research of the pathogenesis of major diseases, translational medicine research, and is a new type of translational medicine research organization integrating industry, academia, research and application.

Zhongke Jianlan established in vitro diagnostic systems centered on new disease targets, developed multi-disease detection reagents and supporting instruments, and created a new mode of immuno-evolutionary therapy for major diseases.

Adhering to the philosophy that science leads to health and innovation accomplishes the future, Zhongke Jianlan is committed to tracking the frontier of life sciences, linking with global medical innovations, embracing glory and dreams, and arriving at the other side of the shore of health.

Core Technologies

Antibody Engineering  A technology that utilizes recombinant DNA and protein engineering techniques to modify and reassemble antibody genes to express antibody molecules with specific functions.

Gene Editing  The modification of specific targets in an organism's genome by specific techniques to achieve gene insertions, deletions, or substitutions that alter its genetic information and phenotypic characteristics.

Immune Evolution  The modification of the structure and function of the immune system through manipulation of immune genes and clonal selection to drive the evolution of the immune system to adapt to the environment and defend against disease.

Cell Therapy  The use of the biological properties of stem cells or immune cells to treat disease or promote tissue repair by transplanting or modifying specific types of cells.

Project Cluster

Antibody
Reagent
Equipment
Detection
Cell
Supplement
Facial
Healthcare

Antibody Drugs  Anti-Bladder Cancer Antibody, Anti-Prostate Cancer Antibody, Anti-Lung Cancer Antibody, Anti-Hepatocellular Carcinoma Antibody, Anti-CD47 Antibody, Anti-CTLA4 Antibody, Anti-TIGIT Antibody, Anti-TIM3 Antibody, Anti-OX40 Antibody, Anti-Amyloid Antibody.

Diagnostic Reagents  Tumor Series, Inflammation Series, Cardiovascular Series, Respiratory Series, Eugenics Series, Infertility Series, Pathogenic Microorganism Series, Cytokine Series, Liver Disease Series, Endocrine Series, Autoimmune Series.

Medical Equipment  New AI Pathology Rapid Imaging System, Wireless Muscle Training System, Digital Cell Detection and Repair Instrument, Multi-functional Fluorescence Analyzer, Automatic Biochemical Analyzer, Head-mounted Brain Glioma Assistive Device, Pulsed Field Ablation Device.

Detection Technology  Time-resolved immunofluorescence, quantum dot immunofluorescence, chemiluminescence technology, microfluidic chip analysis, single-cell transcriptome sequencing, single-molecule immunoarray, circulating cell CTC detection, latex particle enhanced turbidimetric analysis.

Cell Preparation  Umbilical Cord Stem Cells, Embryonic Stem Cells, Hematopoietic Stem Cells, Placental Amniotic Stem Cells, Adipose Stem Cells, NK Cells, CAR-T Cells, CAR-NK Cells, DC-CIK Cells, TIL Cells, Induced Pluripotent Stem Cells.

Dietary supplements  Whole Nutritional Preparation, Complex Plant Selenium, Nodal Clearing Preparation, Immune Microecology, Assisting in Lowering Blood Sugar, Assisting in Lowering Uric Acid, Assisting in Lowering Blood Lipid, Assisting in Lowering Blood Pressure, Immunity Balance, Nerve Nutrition, Protecting Liver and Nourishing Stomach, Improving Sleep.

Medical Cosmetic Products  Stem Cell Exosome Eyedrops, Stem Cell Exosome Nebulizer Solution, Stem Cell Exosome Nutrient Solution, STL Stem Cell Activation Solution, Ultimate Renewal Essence, Ultimate Renewal Mask, Whitening and Spot Reducing Essence Capsule, Skin Rejuvenation Essence.

Health Services  Genetic Testing, Immune Assessment, Nutritional Monitoring, Alzheimer's Disease Testing, Stroke Screening, Lung Nodule Testing, Cancer Testing, Cardiovascular Testing, New Cancer Screening, Autoimmune Disease Testing, Metabolic Disease Testing.

Scientific Research

Several natural immune recognition receptors have been identified, revealing the role and structural basis of immune cell granzyme in anti-tumor activity, and elucidating the mechanism of its anti-tumor immune recognition response.

The mechanism by which key mutations in cancer cells regulate the self-renewal of tumor stem cells has been discovered.

Several new subpopulations of tumor stem cells with strong tumorigenic ability and self-renewal potential have been identified in cancers.

Multiple new signaling pathways for maintaining stemness in tumor stem cells have been discovered.

It has been found that several non-coding RNAs play crucial regulatory roles in various tumors, making them ideal markers for tumor recurrence and metastasis.

A set of consistent variations associated with neoadjuvant chemotherapy resistance have been identified.

PROJECTS

分享到